Trial Profile
Italian experience of Romidepsin in relapsed/refractory T-cell lymphomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2018
Price :
$35
*
At a glance
- Drugs Romidepsin (Primary)
- Indications T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2018 New trial record